This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the type 2 diabetes and weight loss ...

Natco Pharma has launched the Semaglutide injection in India on the first day of its patent expiry. Hyderabad-based Natco received approval from Central Drugs Standard Control Organisation (CDSCO) to ...

Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent ...

Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...

With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 ...

It will be available tomorrow, day 1 of patent expiry, the Hyderabad-based generic drugmaker said on Friday. Semaglutide is ...

Sun Pharma and Zydus Lifesciences launch affordable generics of semaglutide in India for weight management and diabetes treatment.

Generic drugmakers in India launch affordable Semaglutide versions, targeting a $1 billion diabetes and weight loss market.

Alkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Semaglutide prices in India have dropped sharply after generic launches. Check the latest monthly costs, cheapest options, and vial vs pen price comparison for patients.